BioVex - Nature Biotechnology
Next year, the company plans to begin its first clinical trial with ImmunoVEX for the treatment of malignant melanoma. BioVex also intends to generate ...
http://www.nature.com/nbt/journal/v20/n6s/full/nbt0602supp-B...
|
BioSpace - BioVex News, Search Jobs, Events
OncoVEXGMCSF is currently undergoing a Phase II clinical trial in the US in malignant melanoma. BioVex’s expanded clinical program for OncoVEXGMCSF also ...
http://www.biospace.com/company_profile.aspx?CompanyId=27840...
|
BioPortfolio - BioVex
BioVex - Entry on Bioportfolio's Biocorporate Database. ... The Company’s lead product to treat malignant melanoma is expected to enter the clinic in the ...
http://www.bioportfolio.com/biocorporate/2003-BioVex.html...
|
BioVex Reports Positive Phase II Clinical Trial Results of OncoVEX ...
BioVex is currently completing a Phase II clinical trial of OncoVEX GM-CSF for melanoma and Phase I/II clinical trials for head & neck cancer and pancreatic
...
http://www.biospace.com/news_story.aspx?NewsEntityId=98480...
|
BioPortfolio - BioVex - Profile
BioVex is a three year old private biotech company that is developing a new ... head and neck cancer and malignant melanoma. OncoVEX GM-CSF is scheduled to ...
http://www.bioportfolio.com/biocorporate/2003-BioVex.pdf...
|
BioVex Begins Dosing Patients In Phase II Clinical Trials Of ...
Dr Nemuniatis commented, "Melanoma is a problem of increasing seriousness and BioVex's unique strategy using a dual approach of a potent oncolytic agent, ...
http://www.biospace.com/news_story.aspx?NewsEntityId=9743...
|
BioPortfolio - BioVex
BioVex’s lead product candidate, OncoVEXGM-CSF is in a Phase II clinical trial in melanoma and a Phase I/II clinical trial in head and neck cancer. ...
http://www.bioportfolio.com/biocorporate/19958-BioVex.html...
|
BioVex Closes Second Round of Series E Financing Second and Final ...
BioVex intends to use the capital to complete its preparations for, ... study with its lead product OncoVex GM-CSF for the treatment of melanoma as well as
...
http://www.biospace.com/news_story.aspx?NewsEntityId=77588...
|
BioVex Appoints Genzyme Executive, Jan van Heek, as Chairman of ...
Jan van Heek, Chairman of BioVex Inc, said: "I am excited to be joining BioVex ... is currently completing a Phase II clinical trial for melanoma and Phase ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
BioPortfolio - immunovex vaccine trial
7 Jan 2009 ... http://www.bioportfolio.com/biocorporate/2003-BioVex.pdf... Melanoma - Targeted Therapeutics 9.1.12 Therion’s Melanoma Vaccine 137 9.1.13 ...
http://www.bioportfolio.com/search/immunovex_vaccine_trial.h...
|
